5
Participants
Start Date
July 31, 2000
Primary Completion Date
December 31, 2001
Study Completion Date
April 30, 2002
BMS-214662
This is a dose-escalation study of BMS-214662. BMS-214662 IV over 1 hour on day 3 of course 1. For all subsequent courses, patients receive BMS-214662 IV over 1 hour on day 1 (30 minutes after paclitaxel). Treatment repeats every 3 weeks for at least 2 courses in the absence of disease progression or unacceptable toxicity.
paclitaxel
Patients receive paclitaxel IV over 3 hours on day 1 of course 1. For all subsequent courses, patients receive paclitaxel IV over 3 hours on day 1. Treatment repeats every 3 weeks for at least 2 courses in the absence of disease progression or unacceptable toxicity.
Ireland Cancer Center at University Hospitals Case Medical Center, Cleveland
Arthur G. James Cancer Hospital - Ohio State University, Columbus
National Cancer Institute (NCI)
NIH
Case Comprehensive Cancer Center
OTHER